Blue-Light Endoscope Trial Closed
RICHMOND, BC, Canada--Xillix Technologies Corp. has closed the North American multicenter clinical trial of its LIFE (lung imaging fluorescence endoscope)-Lung Imaging System that began in April, 1993.
RICHMOND, BC, Canada--Xillix Technologies Corp. has closed theNorth American multicenter clinical trial of its LIFE (lung imagingfluorescence endoscope)-Lung Imaging System that began in April,1993.
The system uses tissue autofluo-rescence to enhance the physician'sability to locate suspicious lung tissue for biopsy. By usingblue rather than conventional white light, the system can pickup subtle differences between precancerous or cancerous tissueand normal tissue, the company said.
Preliminary data showed a relative improvement of 161% in theability to identify suspicious tissue for moderate to severe dysplasiaor worse when the LIFE System was used as an adjunct to whitelight bronchoscopy versus white light bronchoscopy alone.
FDA Approves Encorafenib/Cetuximab Plus mFOLFOX6 for Advanced BRAF V600E+ CRC
December 20th 2024The FDA has granted accelerated approval to encorafenib in combination with cetuximab and mFOLFOX6 for patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test.
